Researchers find common immune system mechanism between pregnancy, cancer

By understanding how immune response is suppressed in pregnancy, researchers pinpoint key mechanism that stops immune system from blocking cancer

5:00 AM

Author | Nicole Fawcett

Cancer cell microscopic, colored yellow

To understand why some cancers successfully circumvent the immune system to grow unchecked, researchers turned to pregnancy.

“In pregnancy, the immune system does not reject the growing fetus, so we know there must be mechanisms active in the placenta. In cancer, it’s the same thing: the growing tumor is not rejected by the immune system. It means the cancer cells have developed strategies to suppress immune rejection, same as in pregnancy,” said Weiping Zou, M.D., Ph.D.

It’s a good thing in pregnancy – it allows the baby to grow. But in cancer, it means the tumor grows unchecked and treatments meant to stimulate an immune response are not effective.

To understand this overlap, Zou collaborated with other researchers from the University of Michigan Health Rogel Cancer Center – bringing together unique expertise in immunology, cancer genetics, gynecologic pathology and medicinal chemistry.

They found that indeed there is a molecular mechanism shared in cancer and pregnancy that suppresses the immune system. Block this mechanism, called B7-H4, and the immune system revs up to slow cancer’s growth. Looking at mouse models and cell lines of breast and gynecologic cancers, the researchers identified the hormone progesterone as a key regulator of the B7-H4 immune checkpoint.

The paper is published in Cell.

B7-H4 expression has previously been associated with shorter survival in cancer patients. The Rogel researchers discovered that B7-H4 plays an active role in moderating the immune system in both the placenta and the tumor microenvironment.

Further, while the male hormone androgen has previously been linked to immune suppression in prostate cancer, this is the first time the female sex hormone progesterone has been shown to impact immune response in cancer.

In pregnancy, the immune system does not reject the growing fetus, so we know there must be mechanisms active in the placenta.”

--Weiping Zou, M.D., Ph.D.

Researchers used an inhibitor to block progesterone signaling in mice with breast cancer and in human breast cancer tissue samples, which did slow the cancer’s growth in mice and activated the immune response. The effect was clear but not dramatic, however.

“B7-H4 is an important checkpoint, but it’s complicated,” Zou said. “Progesterone regulation is one mechanism, but we need more studies to understand whether other mechanisms are also involved in regulating B7-H4. We do not have a direct way to block this signaling pathway. The receptors remain unknown.

“There’s something in the basic immunobiology that we still don’t understand.”

Researchers plan additional studies looking at mechanisms regulating B7-H4 protein stability, as well as the role other factors plays in cancer immunology.

Additional authors: Jiali Yu, Yijian Yan, Shasha Li, Ying Xu, Abhijit Parolia, Syed Rizvi, Weichao Wang, Yiwen Zhai, Rongxin Xiao, Xiong Li, Peng Liao, Jiajia Zhou, Karolina Okla, Heng Lin, Xun Lin, Sara Grove, Shuang Wei, Linda Vatan, Jiantao Hu, Justyna Szumilo, Jan Kotarski, Zachary T. Freeman, Stephanie Skala, Max Wicha, Kathleen R. Cho, Arul M. Chinnaiyan, Samantha Schon, Fei Wen, Ilona Kryczek, Shaomeng Wang, Lieping Chen

Funding: National Cancer Institute grants CA217648, CA123088, CA099985, CA193136, CA152470, CA46592; UTC-Yale Endowment 

This work was supported by these Rogel Cancer Center Shared Resources: Immune Monitoring, Transgenic Animal Models, Cell and Tissue Imaging

Paper cited: “Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance,”Cell. DOI: 10.1016/j.cell.2024.06.012

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week by subscribing to Health Lab’s two newsletters, Health & Wellness and Research & Innovation.

Sign up for the Health Lab Podcast: Add us on Spotify, Apple Podcasts or wherever you get you listen to your favorite shows.

 


More Articles About:

Cancer (Oncology) Cancer Treatment Pregnancy women's health All Research Topics Basic Science and Laboratory Research
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

zou weiping

Weiping Zou

Professor

Related

T-cell attaching to cancer cell
Health Lab

Cancer Immunotherapy May Also Treat Certain Autoimmune Diseases

The new approach blocks the interaction between cancer cells and immune receptors, showing promise in mice.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Mother sits on a couch with a laptop on her lap while an elementary school age boy sits next to her playing on a tablet device.
Health Lab

New questionnaire aims to improve understanding of demand avoidance in children, teens

Pathological demand avoidance is a pattern of intense distress and avoidance of demands in children. A new questionnaire from University of Michigan researchers creates a structured way to assess these behaviors.
Blue round cells in three pictures showing how they change under stress.
Health Lab

Timing is of the essence for RNA during stress

Key determiners of which RNA can be read to make proteins is time. Previous thinking was that a cell under threat would quickly make these RNAs in the nucleus and immediately push them into the cytoplasm.
Blue and yellow illustration of DNA helix
Health Lab

New anti-cancer strategy shows promise in preclinical studies

New cancer therapeutic strategy rewires protein interactions to improve efficacy and reduce potential side effects.
Closeup of newborn baby, whose head is held by a blue medical gloved hand. Blue gloved hand also holds a stethoscope to baby's chest.
Health Lab

More babies with hypoplastic left heart syndrome surviving critical period between surgeries

Collaborative effort helped sustain improvements in survival for babies born with hypoplastic left heart syndrome (HLHS), a serious congenital heart condition that requires multiple surgeries.
Rachel Upjohn Building groundbreaking ceremony
News Release

How U-M helped bring depression out of the darkness

The history of the founding of the Eisenberg Family Depression Center at the University of Michigan, the nation's first center focused on research, community outreach and stigma reduction in depression and bipolar disorder.
1906 psychopathic hospital
News Release

Exploring the mind’s mysteries: 130 years of mental health care & innovation at U-M

When it opened in 1906 on Catherine Street near the University of Michigan’s main hospitals, the stately brick State Psychopathic Hospital meant something new in the world of mental health.